173 related articles for article (PubMed ID: 1952858)
1. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
Sydnor A; Gwaltney JM; Cocchetto DM; Scheld WM
Arch Otolaryngol Head Neck Surg; 1989 Dec; 115(12):1430-3. PubMed ID: 2510772
[TBL] [Abstract][Full Text] [Related]
3. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Perry CM; Brogden RN
Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.
Baldwin DR; Andrews JM; Wise R; Honeybourne D
J Antimicrob Chemother; 1992 Sep; 30(3):377-85. PubMed ID: 1452503
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefuroxime axetil suspension in infants and children.
Powell DA; James NC; Ossi MJ; Nahata MC; Donn KH
Antimicrob Agents Chemother; 1991 Oct; 35(10):2042-5. PubMed ID: 1759825
[TBL] [Abstract][Full Text] [Related]
7. [Role of cefuroxime-axetil in the treatment of respiratory tract infections. Bacteriological and pharmacological data].
Bergogne-Berezin E; Vallée E; Muller-Serieys C
Therapie; 1991; 46(4):333-7. PubMed ID: 1948811
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
Doern GV; Vautour R
Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of commonly used oral antimicrobial agents against community isolates of respiratory pathogens.
Struelens MJ; Nonhoff C; Lontie M; Delannoy P; Lanis G; Van Pelt H; Serruys E
Acta Clin Belg; 1991; 46(5):283-9. PubMed ID: 1661548
[TBL] [Abstract][Full Text] [Related]
11. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?
Dagan R; Abramson O; Leibovitz E; Greenberg D; Lang R; Goshen S; Yagupsky P; Leiberman A; Fliss DM
J Infect Dis; 1997 Nov; 176(5):1253-9. PubMed ID: 9359726
[TBL] [Abstract][Full Text] [Related]
12. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Dagan R; Abramson O; Leibovitz E; Lang R; Goshen S; Greenberg D; Yagupsky P; Leiberman A; Fliss DM
Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
[TBL] [Abstract][Full Text] [Related]
13. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC
Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851
[TBL] [Abstract][Full Text] [Related]
15. Treatment of otitis media with cefuroxime axetil.
Aronovitz GH
South Med J; 1988 Aug; 81(8):978-80. PubMed ID: 3043692
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of cefaclor breakpoints for Haemophilus influenzae.
MacKenzie FM; Milne KE; Gould IM
J Chemother; 2004 Aug; 16(4):329-33. PubMed ID: 15332705
[TBL] [Abstract][Full Text] [Related]
17. Determination of antimicrobial activity of Cefaclor on common respiratory tract pathogens in Pakistan.
Ahmed A; Hafiz S; Rafiq M; Tariq N; Abdulla EM; Hussain S; Azim R; Siddiqui SJ; Awan A; Khan KZ; Fareed A
J Pak Med Assoc; 2002 Jan; 52(1):7-11. PubMed ID: 11963587
[TBL] [Abstract][Full Text] [Related]
18. Measuring antibiotic levels in otitis media.
Thoroddsen E
Ear Nose Throat J; 1998 Jun; 77(6 Suppl):13-5. PubMed ID: 9674329
[TBL] [Abstract][Full Text] [Related]
19. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of cefuroxime axetil suspension and amoxycillin syrup in the treatment of acute otitis media in general practice.
Brodie DP; Griggs JV; Cunningham K
J Int Med Res; 1990; 18(3):235-9. PubMed ID: 2113874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
